Supplements and Featured Publications
Translating Clinical Guidelines Into Practice: The Effective and Appropriate Use of Human Growth Hor
Volume: 19
Issue: 15 Suppl
NSAIDs: Optimizing Pain Management Through Risk Reduction
Volume: 19
Issue: 14 Suppl
Management of Patients with Homozygous Familial Hypercholesterolemia
Volume: 19
Issue: 13 Suppl
Addressing Adherence Challenges Associated With Antiretroviral Therapy: Focus on Noninfectious Diarr
Volume: 19
Issue: 12 Suppl
The Clinical and Economic Consequences of Obesity
Volume: 19
Issue: 11 Suppl
The Quality Enterprise—What Is It, Where Is It Going, and How Will It Be Impacted by Healthcare Reform?
Volume: 19
Issue: 9 Suppl
The Clinical, Social, and Economic Implications of Neurogenic Bladder in Managed Care: Optimizing Pa
Volume: 19
Issue: 10 Suppl
Pathways to Success: Utilizing Managed Care Models to Improve Clinical and Economic Outcomes in Diab
Volume: 19
Issue: 8 Suppl
Hereditary Angioedema: Facilitating Diagnosis and Optimizing Clinical and Economic Outcomes [CPE/CME
Volume: 19
Issue: 7 Suppl
Value-Based Insurance Design: Perspectives, Extending the Evidence, and Implications for the Future
The Economic Impact of Medicare Part D on Congestive Heart Failure
Volume: 19
Issue: 6 Suppl
![Addressing the Clinical and Managed Care Challenges in Treating Diseases of the Aging Eye [CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/4ad1f4047a64cc2f0f60d8e454804f78c24e866c-879x1200.png?w=230&fit=crop&auto=format)
Addressing the Clinical and Managed Care Challenges in Treating Diseases of the Aging Eye [CPE]
Volume: 19
Issue: 5 Suppl
The Clinical and Psychosocial Impact of Peyronie’s Disease
Volume: 19
Issue: 4 Suppl
Managing Costs in High-Risk Obstetrics
Type 2 Diabetes and the Evolving Paradigm in Glucose Regulation
Volume: 19
Issue: 3 Suppl
![Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CPE]](https://cdn.sanity.io/images/0vv8moc6/ajmc/6594629bd041f089213fa76b19562bda6baeb63d-300x409.jpg?w=230&fit=crop&auto=format)
Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CPE]
Volume: 19
Issue: 2 Suppl
Unmet Need in the Treatment of Postherpetic Neuralgia
Volume: 19
Issue: 1 Suppl
Chronic Obstructive Pulmonary Disease From a Payer and Provider Lens
Battling a Stormy C: Addressing Managed Care Challenges and Opportunities in Management of Hepatitis
Volume: 18
Issue: 14 Suppl
Improving Clinical and Managed Care Outcomes in Rheumatoid arthritis: a Focus on Comparative Effecti
Volume: 18
Issue: 13 Suppl
Improving Outcomes for Restless Legs Syndrome: Considerations for Managed Care—A Clinician and Pay
Volume: 18
Issue: 12 Suppl
New Approaches to Measuring Value in Oncology Therapy
Volume: 18
Issue: 11 Suppl
Emerging Type 2 Diabetes Treatment Strategies: Practical Solutions for a Complex Environment [CME/CP
Volume: 18
Issue: 10 Suppl
A Novel Gastroretentive Formulation of Gabapentin for the Treatment of Postherpetic Neuralgia
Improving Outcomes for Restless Legs Syndrome: Considerations for Managed Care—A Clinician and Pay
Volume: 18
Issue: 9 Suppl
Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Re
Volume: 18
Issue: 8 Suppl
Best Practices for Treating Parkinson’s Disease: A Focus on Symptoms and Considerations for Manage
Volume: 18
Issue: 7 Suppl
The Aligning Forces for Quality Initiative: Early Lessons From Efforts to Improve Healthcare Quality
Volume: 18
Issue: 6 Suppl
Improving Outcomes for Restless Legs Syndrome: Considerations for Managed Care—a Clinician and Pay
Volume: 18
Issue: 5 Suppl
Considerations for the Optimal Use of Immunoglobulin
Volume: 18
Issue: 4 Suppl
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG
3
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
4
How Effective and Safe Are GLP-1s for Weight Loss?
5
